Opinion: A Wolf in Sheep’s Clothing

Nutrition research must overcome pseudoscientific measures and self-interest to make progress in the fight against obesity.

Written byEdward Archer
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA, USDARecently, I was the lead author on a paper demonstrating that about 40 years and many millions of dollars of US nutritional surveillance data were fatally flawed. In most research domains, such a finding might be monumental; yet in nutrition epidemiology—the study of the impact of diet on health, hereafter referred to simply as “nutrition”—these results are commonplace. In fact, there is a large body of evidence demonstrating that the systematic misreporting of energy and macronutrient intake renders the results and conclusions of the vast majority of federally funded nutrition studies invalid.

So what is going on? Is such research mere pseudoscience? And if so, how can the federal government continue to spend billions of taxpayer dollars on studies that are making no demonstrable progress in our nation’s fight against obesity and diabetes?

We may be witnessing the confluence of two inherent components of the human condition: incompetence and self-interest. Nutrition has had many colossal and costly failures. The list of dietary components claimed to reduce cardiovascular disease (CVD), prevent cognitive decline, and/or fight cancer that were later refuted via clinical trials is extensive. And while the self-correcting nature of science necessitates failure, the vast majority of nutrition’s failures were engendered by a complete lack of familiarity with the scientific method. This deficit is most apparent in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies